It is a link for moving within the page.

  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2015
  5. A Marker to Monitor Treatment Effectiveness For Chronic Myeloid Leukemia(CML) Otsuka's Major BCR-ABL mRNA Measurement Kit Covered by Health Insurance in Japan as of April 1

April 1, 2015

Otsuka Pharmaceutical Co., Ltd.

Pharmaceuticals

A Marker to Monitor Treatment Effectiveness For Chronic Myeloid Leukemia(CML) Otsuka's Major BCR-ABL mRNA Measurement Kit Covered by Health Insurance in Japan as of April 1

Otsuka Pharmaceutical Co., Ltd. announced that it received notification in Japan that as of April 1 insurance coverage is be provided for use of the Otsuka Major BCR-ABL mRNA Measurement Kit. The kit is an extracorporeal diagnostic pharmaceutical product meeting international standards for use as an aid to diagnose and monitor treatment effectiveness for chronic myeloid leukemia (CML). 


Information in this news release was current as of the original release date.

Latest Pharmaceutical Business related News Releases

Most Recent Releases